Literature DB >> 18953060

Invited commentary: Preventing neural tube defects and more via food fortification?

James L Mills1, Tonia C Carter.   

Abstract

Many neural tube defects can be prevented if women take folic acid around the time of conception. However, the majority of women do not take folic acid at the critical time, so the US government required that food be fortified with folic acid effective January 1, 1998. Whether the amount being added was sufficient to prevent all folate-related neural tube defects has been hotly debated. Mosley et al. (Am J Epidemiol. 2008;169(1):9-17) found no evidence that folic acid supplement use or dietary folate intake was related to neural tube defects, indicating that fortified food is probably providing sufficient folic acid to prevent folate-related defects. Because data on the effectiveness of fortification in the United States are scarce, this is an important contribution. There is great interest in the other effects of fortification. Folic acid reduces homocysteine levels, and homocysteine has been linked to cardiovascular disease and cancer. On the basis of current evidence, however, it seems unlikely that fortification will reduce cardiovascular disease rates. Its effect on cancer remains unclear. Folic acid may be useful in primary prevention but may also stimulate the growth of existing malignancies or premalignant lesions. Although these issues remain unresolved, Mosley et al. have provided important data to address the primary question: Does fortification prevent folate-related neural tube defects?

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18953060      PMCID: PMC2720707          DOI: 10.1093/aje/kwn329

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  36 in total

1.  Homocysteine and folate as risk factors for dementia and Alzheimer disease.

Authors:  Giovanni Ravaglia; Paola Forti; Fabiola Maioli; Mabel Martelli; Lucia Servadei; Nicoletta Brunetti; Elisa Porcellini; Federico Licastro
Journal:  Am J Clin Nutr       Date:  2005-09       Impact factor: 7.045

2.  High homocysteine and low B vitamins predict cognitive decline in aging men: the Veterans Affairs Normative Aging Study.

Authors:  Katherine L Tucker; Ning Qiao; Tammy Scott; Irwin Rosenberg; Avron Spiro
Journal:  Am J Clin Nutr       Date:  2005-09       Impact factor: 7.045

3.  A controlled trial of homocysteine lowering and cognitive performance.

Authors:  Jennifer A McMahon; Timothy J Green; C Murray Skeaff; Robert G Knight; Jim I Mann; Sheila M Williams
Journal:  N Engl J Med       Date:  2006-06-29       Impact factor: 91.245

4.  Plasma total homocysteine and memory in the elderly: the Hordaland Homocysteine Study.

Authors:  Eha Nurk; Helga Refsum; Grethe S Tell; Knut Engedal; Stein E Vollset; Per M Ueland; Harald A Nygaard; A David Smith
Journal:  Ann Neurol       Date:  2005-12       Impact factor: 10.422

5.  Dietary intake of folate and co-factors in folate metabolism, MTHFR polymorphisms, and reduced rectal cancer.

Authors:  Maureen A Murtaugh; Karen Curtin; Carol Sweeney; Roger K Wolff; Richard Holubkov; Bette J Caan; Martha L Slattery
Journal:  Cancer Causes Control       Date:  2007-01-23       Impact factor: 2.506

6.  Folate levels and neural tube defects. Implications for prevention.

Authors:  L E Daly; P N Kirke; A Molloy; D G Weir; J M Scott
Journal:  JAMA       Date:  1995-12-06       Impact factor: 56.272

7.  Periconceptional use of multivitamins and the occurrence of neural tube defects.

Authors:  J Mulinare; J F Cordero; J D Erickson; R J Berry
Journal:  JAMA       Date:  1988-12-02       Impact factor: 56.272

8.  Periconceptional folic acid exposure and risk of occurrent neural tube defects.

Authors:  M M Werler; S Shapiro; A A Mitchell
Journal:  JAMA       Date:  1993-03-10       Impact factor: 56.272

9.  Folic acid for the prevention of colorectal adenomas: a randomized clinical trial.

Authors:  Bernard F Cole; John A Baron; Robert S Sandler; Robert W Haile; Dennis J Ahnen; Robert S Bresalier; Gail McKeown-Eyssen; Robert W Summers; Richard I Rothstein; Carol A Burke; Dale C Snover; Timothy R Church; John I Allen; Douglas J Robertson; Gerald J Beck; John H Bond; Tim Byers; Jack S Mandel; Leila A Mott; Loretta H Pearson; Elizabeth L Barry; Judy R Rees; Norman Marcon; Fred Saibil; Per Magne Ueland; E Robert Greenberg
Journal:  JAMA       Date:  2007-06-06       Impact factor: 56.272

10.  Reduction in neural-tube defects after folic acid fortification in Canada.

Authors:  Philippe De Wals; Fassiatou Tairou; Margot I Van Allen; Soo-Hong Uh; R Brian Lowry; Barbara Sibbald; Jane A Evans; Michiel C Van den Hof; Pamela Zimmer; Marian Crowley; Bridget Fernandez; Nora S Lee; Theophile Niyonsenga
Journal:  N Engl J Med       Date:  2007-07-12       Impact factor: 91.245

View more
  5 in total

1.  Reduced risks of neural tube defects and orofacial clefts with higher diet quality.

Authors:  Suzan L Carmichael; Wei Yang; Marcia Lynn Feldkamp; Ronald G Munger; Anna Maria Siega-Riz; Lorenzo D Botto; Gary Shaw
Journal:  Arch Pediatr Adolesc Med       Date:  2011-10-03

2.  Long-term effect of low-dose folic acid intake: potential effect of mandatory fortification on the prevention of neural tube defects.

Authors:  Lisa A Houghton; Andrew R Gray; Meredith C Rose; Jody C Miller; Nicola A Hurthouse; Jesse F Gregory
Journal:  Am J Clin Nutr       Date:  2011-05-18       Impact factor: 7.045

3.  Periconceptional nutrient intakes and risks of neural tube defects in California.

Authors:  Suzan L Carmichael; Wei Yang; Gary M Shaw
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2010-08

4.  Is low iron status a risk factor for neural tube defects?

Authors:  Anne M Molloy; Caitriona Nic Einri; Divyanshu Jain; Eamon Laird; Ruzong Fan; Yifan Wang; John M Scott; Barry Shane; Lawrence C Brody; Peadar N Kirke; James L Mills
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2014-02-18

5.  Folate status of reproductive age women and neural tube defect risk: the effect of long-term folic acid supplementation at doses of 140 µg and 400 µg per day.

Authors:  Nicola A Hursthouse; Andrew R Gray; Jody C Miller; Meredith C Rose; Lisa A Houghton
Journal:  Nutrients       Date:  2011-01-10       Impact factor: 6.706

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.